Response to a case report: Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
Respirol Case Rep
.
2021 Jan 4;9(2):e00707.
doi: 10.1002/rcr2.707.
eCollection 2021 Feb.
Authors
Gema Requena
1
,
Florence Roufosse
2
,
Lee D Baylis
3
,
Jonathan Steinfeld
4
Affiliations
1
Epidemiology, Value Evidence and Outcomes Global R&D, GSK London UK.
2
Department of Internal Medicine, Hôpital Erasme Université Libre de Bruxelles Brussels Belgium.
3
Respiratory Medical Franchise GSK Research Triangle Park NC USA.
4
Respiratory Research & Development GSK Collegeville PA USA.
PMID:
33425360
PMCID:
PMC7780009
DOI:
10.1002/rcr2.707
No abstract available